Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Laser Incubator Developed for Rapid Blood Group Typing

By LabMedica International staff writers
Posted on 01 Oct 2019
Blood transfusion is a critical treatment for a variety of hematological conditions, including cancer chemotherapy, sickle cell disease treatments, bleeding trauma, including childbirth, and major surgery.

Over 21 million blood components are transfused in the USA alone every year; each having the potential for fatal hemolytic transfusion reactions if recipient and donor are not accurately matched. More...
Identification of antigens and antibodies often requires incubation at human body temperature of 37 °C. Depending on the method, this incubation step can take 5 to 30 minutes.

Chemical Engineers at Monash University (Clayton, Australia) and their colleagues at Haemokinesis (Hallam, Australia) developed rapid optical heating via laser, where targeted illumination of a blood-antibody sample in a diagnostic gel card is converted into heat, via photothermal absorption. The laser-incubator heats the 75 µL blood-antibody sample to 37 °C in less than 30 seconds.

Whole blood samples were stored by refrigeration at 4 °C with ethylenediaminetetraacetic acid (EDTA) as anticoagulant and were used within two weeks post-collection. Reagent red blood cell solutions (Haemokinesis: Stargel10 3 cell screen,) were used for all RBC-antibody incubation tests. Immunoglobulin-G (IgG) anti-D antibody was used for all antibody tests except for the sensitivity control test. The RBC-antibody mixtures were prepared directly in the gel card wells (Haemokinesis Stargel10 AHG System). The gel card heating block (Prototype #5, Haemokinesis) has a fixed temperature of 37 °C. Temperature was detected during incubation directly inside the sample volume in a gel card well using a thermocouple probe.

The team showed that red blood cells act as photothermal agents under near-infrared laser incubation, triggering rapid antigen-antibody binding. They detected no significant damage to the cells or antibodies for laser incubations of up to fifteen minutes. They demonstrate laser-incubated immunohaematological testing to be both faster and more sensitive than current best practice, with clearly positive results seen from laser incubations of just 40 seconds.

Clare A. Manderson, PhD, the first author of the study, said, “Giving blood transfusions to people isn't as simple as giving O-negative to anybody. The 'universal donor' of O-negative blood can seriously harm a lot of people, even kill them. The world of pre-transfusion of blood group typing is huge, and it's really important that it's done quickly and accurately to help save lives.” The study was originally published online on August 2, 2019, in the journal Scientific Reports.

Related Links:
Monash University
Haemokinesis


Gold Member
Cardiovascular Risk Test
Metabolic Syndrome Array I & II
Collection and Transport System
PurSafe Plus®
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Blood Glucose Test Strip
AutoSense Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The CloneSeq-SV approach can allow researchers to study how cells within high-grade serous ovarian cancer change over time (Photo courtesy of MSK)

Blood Test Tracks Treatment Resistance in High-Grade Serous Ovarian Cancer

High-grade serous ovarian cancer (HGSOC) is often diagnosed at an advanced stage because it spreads microscopically throughout the abdomen, and although initial surgery and chemotherapy can work, most... Read more

Industry

view channel
Image: Private equity firms Blackstone and TPG have joined forces to acquire Hologic in a major healthcare deal (Photo courtesy of Hologic)

Hologic to be Acquired by Blackstone and TPG

Hologic (Marlborough, MA, USA) has entered into a definitive agreement to be acquired by funds managed by Blackstone (New York, NY, USA) and TPG (San Francisco, CA, USA) in a transaction valued at up to... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.